Evidence map›Paper›PMID 33692812›Full record

ReviewFrontiers in immunology2021

Building the Next Generation of Humanized Hemato-Lymphoid System Mice.

Tijana Martinov, Kelly M McKenna, Wei Hong Tan, Emily J Collins, Allie R Kehret, Jonathan D Linton, Tayla M Olsen, Nour Shobaki, Anthony Rongvaux

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tijana MartinovClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Kelly M McKennaClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Wei Hong TanClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Emily J CollinsClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Allie R KehretClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Jonathan D LintonClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Tayla M OlsenClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Nour ShobakiClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Anthony RongvauxClinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

Targeting macrophages in metastatic cancerR01CA234720 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RONGVAUX, ANTHONY · 2019 to 2023
$2.2M
Regulation of Natural Killer Cells by CaspasesR21AI138011 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RONGVAUX, ANTHONY · 2019 to 2020
$484k
NCI NIH HHS R01 CA234720NIAID NIH HHS R21 AI138011
6 · The paper itself

Abstract

Since the late 1980s, mice have been repopulated with human hematopoietic cells to study the fundamental biology of human hematopoiesis and immunity, as well as a broad range of human diseases

Indexed as

Adaptive ImmunityDisease Models, AnimalHematopoietic Stem Cell TransplantationAnimalsHematopoiesisHematopoietic Stem CellsHeterograftsHumansMicecancerhematopoiesishumanized miceimmunityimmunotherapiesinfectious diseases

Identifiers

PMID33692812
PMCPMC7938325
OpenAlexW3132279575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.